193 related articles for article (PubMed ID: 27432362)
1. Ten-year follow-up of two cohorts with an increased risk of variant CJD: donors to individuals who later developed variant CJD and other recipients of these at-risk donors.
Checchi M; Hewitt PE; Bennett P; Ward HJ; Will RG; Mackenzie JM; Sinka K
Vox Sang; 2016 Nov; 111(4):325-332. PubMed ID: 27432362
[TBL] [Abstract][Full Text] [Related]
2. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
[TBL] [Abstract][Full Text] [Related]
3. Variant CJD and blood transfusion: are there additional cases?
Davidson LR; Llewelyn CA; Mackenzie JM; Hewitt PE; Will RG
Vox Sang; 2014 Oct; 107(3):220-5. PubMed ID: 24916465
[TBL] [Abstract][Full Text] [Related]
4. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
Llewelyn CA; Hewitt PE; Knight RS; Amar K; Cousens S; Mackenzie J; Will RG
Lancet; 2004 Feb; 363(9407):417-21. PubMed ID: 14962520
[TBL] [Abstract][Full Text] [Related]
5. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
[TBL] [Abstract][Full Text] [Related]
6. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
Urwin PJ; Mackenzie JM; Llewelyn CA; Will RG; Hewitt PE
Vox Sang; 2016 May; 110(4):310-6. PubMed ID: 26709606
[TBL] [Abstract][Full Text] [Related]
7. Transfusion transmission of human prion diseases.
Zou S; Fang CT; Schonberger LB
Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
[TBL] [Abstract][Full Text] [Related]
8. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
[TBL] [Abstract][Full Text] [Related]
9. The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products.
Zaman SM; Hill FG; Palmer B; Millar CM; Bone A; Molesworth AM; Connor N; Lee CA; Dolan G; Wilde JT; Gill ON; Makris M
Haemophilia; 2011 Nov; 17(6):931-7. PubMed ID: 21342369
[TBL] [Abstract][Full Text] [Related]
10. Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk.
Crowder LA; Schonberger LB; Dodd RY; Steele WR
Transfusion; 2017 Aug; 57(8):1875-1878. PubMed ID: 28444687
[TBL] [Abstract][Full Text] [Related]
11. Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies.
Ironside JW
Haemophilia; 2006 Mar; 12 Suppl 1():8-15; discussion 26-8. PubMed ID: 16445812
[TBL] [Abstract][Full Text] [Related]
12. A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions.
Gillies M; Chohan G; Llewelyn CA; MacKenzie J; Ward HJ; Hewitt PE; Will RG
Vox Sang; 2009 Oct; 97(3):211-8. PubMed ID: 19671123
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease.
Cooper JK; Andrews N; Ladhani K; Bujaki E; Minor PD
Vox Sang; 2013 Oct; 105(3):196-204. PubMed ID: 23772892
[TBL] [Abstract][Full Text] [Related]
14. Absence of evidence of transfusion transmission risk of Creutzfeldt-Jakob disease in the United States: Results froma 28-year lookback study.
Crowder LA; Dodd RY; Schonberger LB
Transfusion; 2024 Jun; 64(6):980-985. PubMed ID: 38650381
[TBL] [Abstract][Full Text] [Related]
15. The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety.
Hoots WK; Abrams C; Tankersleydagger D
Transfus Med Rev; 2001 Apr; 15(2 Suppl 1):45-59. PubMed ID: 11441420
[TBL] [Abstract][Full Text] [Related]
16. Creutzfeldt-Jakob disease and blood transfusion safety.
Seed CR; Hewitt PE; Dodd RY; Houston F; Cervenakova L
Vox Sang; 2018 Apr; 113(3):220-231. PubMed ID: 29359329
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.
Wroe SJ; Pal S; Siddique D; Hyare H; Macfarlane R; Joiner S; Linehan JM; Brandner S; Wadsworth JD; Hewitt P; Collinge J
Lancet; 2006 Dec; 368(9552):2061-7. PubMed ID: 17161728
[TBL] [Abstract][Full Text] [Related]
18. No evidence of transfusion transmitted sporadic Creutzfeldt-Jakob disease: results from a bi-national cohort study.
Holmqvist J; Wikman A; Pedersen OBV; Nielsen KR; Rostgaard K; Hjalgrim H; Edgren G
Transfusion; 2020 Apr; 60(4):694-697. PubMed ID: 32187687
[TBL] [Abstract][Full Text] [Related]
19. Prions and transfusion medicine.
Budka H
Vox Sang; 2000; 78 Suppl 2():231-8. PubMed ID: 10938959
[TBL] [Abstract][Full Text] [Related]
20. Proceedings of a consensus conference: the screening of blood donors for variant CJD.
Blajchman MA; Goldman M; Webert KE; Vamvakas EC; Hannon J; Delage G
Transfus Med Rev; 2004 Apr; 18(2):73-92. PubMed ID: 15067588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]